发明名称 Bicyclic heterocyclic spiro compounds
摘要 There are provided certain bicyclic heterocyclic compounds that act as M1 muscarinic receptor modulators. Compositions containing these compounds and their use are also disclosed.
申请公布号 US9034891(B2) 申请公布日期 2015.05.19
申请号 US201313804725 申请日期 2013.03.14
申请人 ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH 发明人 Fisher Abraham;Bar-Ner Nira;Nachum Victoria
分类号 C07D513/10;C07D498/10;C07D491/10;C07D491/20;C07D495/10 主分类号 C07D513/10
代理机构 Fourth Dimension IP 代理人 Fourth Dimension IP ;Feigelson Daniel
主权项 1. A method of treating a disease or condition selected from the group consisting of Alzheimer's disease, Insulin resistance syndrome, type-2 diabetes, Parkinson's Disease, Lewy Body Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Lobar Degeneration, comprising administering the compound of the structureor a pharmaceutically acceptable salt thereof, to a patient having such a disease or condition.
地址 Ness Ziona IL